Review



anti mouse immune checkpoint inhibitor ici antibodies for αctla4  (Bio X Cell)


Bioz Verified Symbol Bio X Cell is a verified supplier
Bioz Manufacturer Symbol Bio X Cell manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Bio X Cell anti mouse immune checkpoint inhibitor ici antibodies for αctla4
    Therapeutic efficacy of the Ad-PS2 vaccine combined with ICIs Note the complete regression of tumors in mice treated with the Ad-PS2 vaccine and <t>αCTLA4.</t> Data pooled from two independent experiments (5 mice per group; n = 10) are represented as mean ± SEM. The main comparison is between the combination of the Ad-PS2 vaccine with αCTLA4 and the control groups; no statistical analysis was performed due to complete tumor regression (A) and tumor-free survival (B).
    Anti Mouse Immune Checkpoint Inhibitor Ici Antibodies For αctla4, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 94/100, based on 21 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti mouse immune checkpoint inhibitor ici antibodies for αctla4/product/Bio X Cell
    Average 94 stars, based on 21 article reviews
    anti mouse immune checkpoint inhibitor ici antibodies for αctla4 - by Bioz Stars, 2026-06
    94/100 stars

    Images

    1) Product Images from "Combined prostate cancer vaccine plus immune checkpoint inhibition synergizes to eliminate prostate cancer"

    Article Title: Combined prostate cancer vaccine plus immune checkpoint inhibition synergizes to eliminate prostate cancer

    Journal: iScience

    doi: 10.1016/j.isci.2025.114552

    Therapeutic efficacy of the Ad-PS2 vaccine combined with ICIs Note the complete regression of tumors in mice treated with the Ad-PS2 vaccine and αCTLA4. Data pooled from two independent experiments (5 mice per group; n = 10) are represented as mean ± SEM. The main comparison is between the combination of the Ad-PS2 vaccine with αCTLA4 and the control groups; no statistical analysis was performed due to complete tumor regression (A) and tumor-free survival (B).
    Figure Legend Snippet: Therapeutic efficacy of the Ad-PS2 vaccine combined with ICIs Note the complete regression of tumors in mice treated with the Ad-PS2 vaccine and αCTLA4. Data pooled from two independent experiments (5 mice per group; n = 10) are represented as mean ± SEM. The main comparison is between the combination of the Ad-PS2 vaccine with αCTLA4 and the control groups; no statistical analysis was performed due to complete tumor regression (A) and tumor-free survival (B).

    Techniques Used: Drug discovery, Comparison, Control

    Therapeutic efficacy of the Ad-PS2 vaccine combined with different doses of αCTLA4 (A) Overall measurement of tumor growth in mice injected with 100 or 200 μg of αCTLA in combination with the Ad-PS2 vaccine; (B) tumor growth curve for individual mouse receiving 100 μg of αCTLA ± Ad-PS2 and control groups pooled from two independent experiments ( n is the number of mice), and (C) rechallenging of tumor-free mice treated with the Ad-PS2 vaccine combined with αCTLA4 from two sets of experiments ( n = 9). Data are represented as mean ± SEM.
    Figure Legend Snippet: Therapeutic efficacy of the Ad-PS2 vaccine combined with different doses of αCTLA4 (A) Overall measurement of tumor growth in mice injected with 100 or 200 μg of αCTLA in combination with the Ad-PS2 vaccine; (B) tumor growth curve for individual mouse receiving 100 μg of αCTLA ± Ad-PS2 and control groups pooled from two independent experiments ( n is the number of mice), and (C) rechallenging of tumor-free mice treated with the Ad-PS2 vaccine combined with αCTLA4 from two sets of experiments ( n = 9). Data are represented as mean ± SEM.

    Techniques Used: Drug discovery, Injection, Control

    Preclinical evaluation of the toxic profile of the Ad-PS2 vaccine combined with αCTLA4 therapy (A) Scatterplot of the counted inflammatory cells in the liver (3 different fields at 40x) between age-matched naive mice and vaccine-treated groups of mice ( n = 3) based on histopathology studies, and (B) liver panel analytes measured in serum among the naive ( n = 3), Ad-LacZ control ( n = 5), Ad-PS2 vaccine ( n = 7), and Ad-PS2 + αCTLA4 ( n = 3) groups of mice. Data are shown as mean ± SEM with a significant difference (∗ p < 0.05) and ns = non-significant following a nonparametric Kruskal-Wallis test.
    Figure Legend Snippet: Preclinical evaluation of the toxic profile of the Ad-PS2 vaccine combined with αCTLA4 therapy (A) Scatterplot of the counted inflammatory cells in the liver (3 different fields at 40x) between age-matched naive mice and vaccine-treated groups of mice ( n = 3) based on histopathology studies, and (B) liver panel analytes measured in serum among the naive ( n = 3), Ad-LacZ control ( n = 5), Ad-PS2 vaccine ( n = 7), and Ad-PS2 + αCTLA4 ( n = 3) groups of mice. Data are shown as mean ± SEM with a significant difference (∗ p < 0.05) and ns = non-significant following a nonparametric Kruskal-Wallis test.

    Techniques Used: Histopathology, Control



    Similar Products

    93
    Genovis Inc selection operator ici immune checkpoint inhibitor roi regions
    Selection Operator Ici Immune Checkpoint Inhibitor Roi Regions, supplied by Genovis Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/selection operator ici immune checkpoint inhibitor roi regions/product/Genovis Inc
    Average 93 stars, based on 1 article reviews
    selection operator ici immune checkpoint inhibitor roi regions - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    94
    Bio X Cell anti mouse immune checkpoint inhibitor ici antibodies for αctla4
    Therapeutic efficacy of the Ad-PS2 vaccine combined with ICIs Note the complete regression of tumors in mice treated with the Ad-PS2 vaccine and <t>αCTLA4.</t> Data pooled from two independent experiments (5 mice per group; n = 10) are represented as mean ± SEM. The main comparison is between the combination of the Ad-PS2 vaccine with αCTLA4 and the control groups; no statistical analysis was performed due to complete tumor regression (A) and tumor-free survival (B).
    Anti Mouse Immune Checkpoint Inhibitor Ici Antibodies For αctla4, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti mouse immune checkpoint inhibitor ici antibodies for αctla4/product/Bio X Cell
    Average 94 stars, based on 1 article reviews
    anti mouse immune checkpoint inhibitor ici antibodies for αctla4 - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    96
    Bio X Cell immune checkpoint inhibitors icis
    Therapeutic efficacy of the Ad-PS2 vaccine combined with ICIs Note the complete regression of tumors in mice treated with the Ad-PS2 vaccine and <t>αCTLA4.</t> Data pooled from two independent experiments (5 mice per group; n = 10) are represented as mean ± SEM. The main comparison is between the combination of the Ad-PS2 vaccine with αCTLA4 and the control groups; no statistical analysis was performed due to complete tumor regression (A) and tumor-free survival (B).
    Immune Checkpoint Inhibitors Icis, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/immune checkpoint inhibitors icis/product/Bio X Cell
    Average 96 stars, based on 1 article reviews
    immune checkpoint inhibitors icis - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    86
    Biotechnology Information hct hematopoietic cell transplantation ici immune checkpoint inhibitors maldi tof matrix assisted laser desorption ionization time
    Therapeutic efficacy of the Ad-PS2 vaccine combined with ICIs Note the complete regression of tumors in mice treated with the Ad-PS2 vaccine and <t>αCTLA4.</t> Data pooled from two independent experiments (5 mice per group; n = 10) are represented as mean ± SEM. The main comparison is between the combination of the Ad-PS2 vaccine with αCTLA4 and the control groups; no statistical analysis was performed due to complete tumor regression (A) and tumor-free survival (B).
    Hct Hematopoietic Cell Transplantation Ici Immune Checkpoint Inhibitors Maldi Tof Matrix Assisted Laser Desorption Ionization Time, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hct hematopoietic cell transplantation ici immune checkpoint inhibitors maldi tof matrix assisted laser desorption ionization time/product/Biotechnology Information
    Average 86 stars, based on 1 article reviews
    hct hematopoietic cell transplantation ici immune checkpoint inhibitors maldi tof matrix assisted laser desorption ionization time - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Pfizer Inc immune checkpoint inhibitors icis
    Therapeutic efficacy of the Ad-PS2 vaccine combined with ICIs Note the complete regression of tumors in mice treated with the Ad-PS2 vaccine and <t>αCTLA4.</t> Data pooled from two independent experiments (5 mice per group; n = 10) are represented as mean ± SEM. The main comparison is between the combination of the Ad-PS2 vaccine with αCTLA4 and the control groups; no statistical analysis was performed due to complete tumor regression (A) and tumor-free survival (B).
    Immune Checkpoint Inhibitors Icis, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/immune checkpoint inhibitors icis/product/Pfizer Inc
    Average 86 stars, based on 1 article reviews
    immune checkpoint inhibitors icis - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    90
    Innovative Therapies immune checkpoint inhibitors (icis)
    Therapeutic efficacy of the Ad-PS2 vaccine combined with ICIs Note the complete regression of tumors in mice treated with the Ad-PS2 vaccine and <t>αCTLA4.</t> Data pooled from two independent experiments (5 mice per group; n = 10) are represented as mean ± SEM. The main comparison is between the combination of the Ad-PS2 vaccine with αCTLA4 and the control groups; no statistical analysis was performed due to complete tumor regression (A) and tumor-free survival (B).
    Immune Checkpoint Inhibitors (Icis), supplied by Innovative Therapies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/immune checkpoint inhibitors (icis)/product/Innovative Therapies
    Average 90 stars, based on 1 article reviews
    immune checkpoint inhibitors (icis) - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Taiho Pharmaceutical immune checkpoint inhibitors (icis) targeting programmed death ligand-1 (pd-l1)
    Therapeutic efficacy of the Ad-PS2 vaccine combined with ICIs Note the complete regression of tumors in mice treated with the Ad-PS2 vaccine and <t>αCTLA4.</t> Data pooled from two independent experiments (5 mice per group; n = 10) are represented as mean ± SEM. The main comparison is between the combination of the Ad-PS2 vaccine with αCTLA4 and the control groups; no statistical analysis was performed due to complete tumor regression (A) and tumor-free survival (B).
    Immune Checkpoint Inhibitors (Icis) Targeting Programmed Death Ligand 1 (Pd L1), supplied by Taiho Pharmaceutical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/immune checkpoint inhibitors (icis) targeting programmed death ligand-1 (pd-l1)/product/Taiho Pharmaceutical
    Average 90 stars, based on 1 article reviews
    immune checkpoint inhibitors (icis) targeting programmed death ligand-1 (pd-l1) - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Innovative Therapies immune checkpoint inhibitor (ici)
    Therapeutic efficacy of the Ad-PS2 vaccine combined with ICIs Note the complete regression of tumors in mice treated with the Ad-PS2 vaccine and <t>αCTLA4.</t> Data pooled from two independent experiments (5 mice per group; n = 10) are represented as mean ± SEM. The main comparison is between the combination of the Ad-PS2 vaccine with αCTLA4 and the control groups; no statistical analysis was performed due to complete tumor regression (A) and tumor-free survival (B).
    Immune Checkpoint Inhibitor (Ici), supplied by Innovative Therapies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/immune checkpoint inhibitor (ici)/product/Innovative Therapies
    Average 90 stars, based on 1 article reviews
    immune checkpoint inhibitor (ici) - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    86
    Immunome Inc ici immune checkpoint inhibitor luad lung adenocarcinoma ips immunophenoscore irgs immune
    Therapeutic efficacy of the Ad-PS2 vaccine combined with ICIs Note the complete regression of tumors in mice treated with the Ad-PS2 vaccine and <t>αCTLA4.</t> Data pooled from two independent experiments (5 mice per group; n = 10) are represented as mean ± SEM. The main comparison is between the combination of the Ad-PS2 vaccine with αCTLA4 and the control groups; no statistical analysis was performed due to complete tumor regression (A) and tumor-free survival (B).
    Ici Immune Checkpoint Inhibitor Luad Lung Adenocarcinoma Ips Immunophenoscore Irgs Immune, supplied by Immunome Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ici immune checkpoint inhibitor luad lung adenocarcinoma ips immunophenoscore irgs immune/product/Immunome Inc
    Average 86 stars, based on 1 article reviews
    ici immune checkpoint inhibitor luad lung adenocarcinoma ips immunophenoscore irgs immune - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    Image Search Results


    Therapeutic efficacy of the Ad-PS2 vaccine combined with ICIs Note the complete regression of tumors in mice treated with the Ad-PS2 vaccine and αCTLA4. Data pooled from two independent experiments (5 mice per group; n = 10) are represented as mean ± SEM. The main comparison is between the combination of the Ad-PS2 vaccine with αCTLA4 and the control groups; no statistical analysis was performed due to complete tumor regression (A) and tumor-free survival (B).

    Journal: iScience

    Article Title: Combined prostate cancer vaccine plus immune checkpoint inhibition synergizes to eliminate prostate cancer

    doi: 10.1016/j.isci.2025.114552

    Figure Lengend Snippet: Therapeutic efficacy of the Ad-PS2 vaccine combined with ICIs Note the complete regression of tumors in mice treated with the Ad-PS2 vaccine and αCTLA4. Data pooled from two independent experiments (5 mice per group; n = 10) are represented as mean ± SEM. The main comparison is between the combination of the Ad-PS2 vaccine with αCTLA4 and the control groups; no statistical analysis was performed due to complete tumor regression (A) and tumor-free survival (B).

    Article Snippet: Anti-mouse immune checkpoint inhibitor (ICI) antibodies for αCTLA4 (Cat. #BP0164; Clone #9D9) and αPD1 (Cat. #BP0146; Clone # RMP1-14) were purchased from BioXcell (Lebanon, NH, USA).

    Techniques: Drug discovery, Comparison, Control

    Therapeutic efficacy of the Ad-PS2 vaccine combined with different doses of αCTLA4 (A) Overall measurement of tumor growth in mice injected with 100 or 200 μg of αCTLA in combination with the Ad-PS2 vaccine; (B) tumor growth curve for individual mouse receiving 100 μg of αCTLA ± Ad-PS2 and control groups pooled from two independent experiments ( n is the number of mice), and (C) rechallenging of tumor-free mice treated with the Ad-PS2 vaccine combined with αCTLA4 from two sets of experiments ( n = 9). Data are represented as mean ± SEM.

    Journal: iScience

    Article Title: Combined prostate cancer vaccine plus immune checkpoint inhibition synergizes to eliminate prostate cancer

    doi: 10.1016/j.isci.2025.114552

    Figure Lengend Snippet: Therapeutic efficacy of the Ad-PS2 vaccine combined with different doses of αCTLA4 (A) Overall measurement of tumor growth in mice injected with 100 or 200 μg of αCTLA in combination with the Ad-PS2 vaccine; (B) tumor growth curve for individual mouse receiving 100 μg of αCTLA ± Ad-PS2 and control groups pooled from two independent experiments ( n is the number of mice), and (C) rechallenging of tumor-free mice treated with the Ad-PS2 vaccine combined with αCTLA4 from two sets of experiments ( n = 9). Data are represented as mean ± SEM.

    Article Snippet: Anti-mouse immune checkpoint inhibitor (ICI) antibodies for αCTLA4 (Cat. #BP0164; Clone #9D9) and αPD1 (Cat. #BP0146; Clone # RMP1-14) were purchased from BioXcell (Lebanon, NH, USA).

    Techniques: Drug discovery, Injection, Control

    Preclinical evaluation of the toxic profile of the Ad-PS2 vaccine combined with αCTLA4 therapy (A) Scatterplot of the counted inflammatory cells in the liver (3 different fields at 40x) between age-matched naive mice and vaccine-treated groups of mice ( n = 3) based on histopathology studies, and (B) liver panel analytes measured in serum among the naive ( n = 3), Ad-LacZ control ( n = 5), Ad-PS2 vaccine ( n = 7), and Ad-PS2 + αCTLA4 ( n = 3) groups of mice. Data are shown as mean ± SEM with a significant difference (∗ p < 0.05) and ns = non-significant following a nonparametric Kruskal-Wallis test.

    Journal: iScience

    Article Title: Combined prostate cancer vaccine plus immune checkpoint inhibition synergizes to eliminate prostate cancer

    doi: 10.1016/j.isci.2025.114552

    Figure Lengend Snippet: Preclinical evaluation of the toxic profile of the Ad-PS2 vaccine combined with αCTLA4 therapy (A) Scatterplot of the counted inflammatory cells in the liver (3 different fields at 40x) between age-matched naive mice and vaccine-treated groups of mice ( n = 3) based on histopathology studies, and (B) liver panel analytes measured in serum among the naive ( n = 3), Ad-LacZ control ( n = 5), Ad-PS2 vaccine ( n = 7), and Ad-PS2 + αCTLA4 ( n = 3) groups of mice. Data are shown as mean ± SEM with a significant difference (∗ p < 0.05) and ns = non-significant following a nonparametric Kruskal-Wallis test.

    Article Snippet: Anti-mouse immune checkpoint inhibitor (ICI) antibodies for αCTLA4 (Cat. #BP0164; Clone #9D9) and αPD1 (Cat. #BP0146; Clone # RMP1-14) were purchased from BioXcell (Lebanon, NH, USA).

    Techniques: Histopathology, Control